Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorBone MarrowPeripheral Blood Stem Cell TransplantationMultiple MyelomaTransplantation, HomologousMelphalanBone Marrow TransplantationTransplantation ConditioningCombined Modality TherapyBone Marrow CellsGranulocytesTreatment OutcomeRemission InductionHematopoietic Stem CellsCyclophosphamideStem CellsSalvage TherapyHematopoietic Stem Cell MobilizationDisease-Free SurvivalEtoposideHodgkin DiseaseLymphoma, Non-HodgkinCytarabineRecurrenceBone Marrow PurgingSurvival RateCarmustineGraft vs Host DiseaseMyeloablative AgonistsSurvival AnalysisThiotepaWhole-Body IrradiationVincristineDoxorubicinHematologic NeoplasmsNeutropeniaPrognosisBusulfanAntigens, CD34Retrospective StudiesLymphoma, Mantle-CellAntineoplastic AgentsAmyloidosisGraft SurvivalHematopoiesisBone and BonesDexamethasoneFollow-Up StudiesReceptors, Granulocyte Colony-Stimulating FactorTime FactorsBoronic AcidsAntineoplastic Agents, AlkylatingPyrazinesChemotherapy, AdjuvantAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularIfosfamideLymphoma, T-Cell, PeripheralCell DifferentiationAutograftsInduction ChemotherapyLymphomaMesenchymal Stem Cell TransplantationThalidomideLeukemia, Myeloid, AcuteLeukocyte CountLiver TransplantationLeukapheresisTransplantation ChimeraRecombinant ProteinsNeoplasm, ResidualPrednisoneCisplatinPodophyllotoxinCells, CulturedLymphoma, Large B-Cell, DiffuseColony-Forming Units AssayTissue DonorsMyelodysplastic SyndromesMaintenance ChemotherapyCell TransplantationAntibodies, MonoclonalCord Blood Stem Cell TransplantationCarboplatinLeukemia, MyeloidColony-Stimulating FactorsMitoxantroneLymphoma, B-CellProspective StudiesVision, EntopticLeukemiaDrug Administration ScheduleBone Marrow DiseasesIdarubicinNeoplasm Recurrence, LocalNeoplasms, Second Primary